Cedars-Sinai investigators have discovered that large oncosomes—fluid-filled sacs released into the bloodstream by aggressive ...

The ability to analyze gene expression at the single-cell level—known as single-cell RNA sequencing (scRNA-seq)—has transformed life sciences, driving discoveries across immunology, oncology, and ...

With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and ...

This article makes a valuable contribution to the field by uncovering a molecular mechanism for miRNA intracellular retention, mediated by the interaction of PCBP2, SYNCRIP, and specific miRNA motifs.

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

A University of California, Riverside-led team has made an advance in the basic understanding of Plasmodium falciparum, the ...

Using an inexpensive electrode coated with DNA, MIT researchers have designed disposable diagnostics that could be adapted to detect a variety of diseases, including cancer or infectious diseases such ...

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component of this system are pattern recognition receptors, which recognize non-self ...

Terrana Biosciences will develop crop protection inputs using RNA technology, which was used by Flagship portfolio company ...

With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

Terrana is aiming to have commercially available products in the next few years, pending regulatory approval, that can be applied as sprayables or seed treatments. And the company says its RNA-based ...